Proopiomelanocortin (POMC) expression and conditioned place aversion during protracted withdrawal from chronic intermittent escalating-dose heroin in POMC-EGFP promoter transgenic mice

Neuroscience

Volumn 236, Issue , 2013, Pages 220-232

  Niikura, K ^a   Zhou, Y ^a   Ho, A ^a   Kreek, M J ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Amygdala; Bacterial artificial chromosome transgenic mice; Conditioned place aversion; Heroin withdrawal; Hippocampus; Proopiomelanocortin

Indexed keywords

DIAMORPHINE; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA;

AMYGDALOID NUCLEUS; ANIMAL CELL; ARCUATE NUCLEUS; ARTICLE; AVERSION; BACTERIAL ARTIFICIAL CHROMOSOME; BODY WEIGHT; CONTROLLED STUDY; DENTATE GYRUS; EMOTION; HIPPOCAMPUS; HYPOTHALAMUS; LONG TERM EXPOSURE; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; HEROIN DEPENDENCE; MICE; MICE, TRANSGENIC; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS, GENETIC; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84874535833     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.12.071     Document Type: Article

References (63)

1. Ahmed S.H., Walker J.R., Koob G.F. Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 2000, 22:413-421.
2. Beauchamp G.K., Yamazaki K. Chemical signalling in mice. Biochem Soc Trans 2003, 31:147-151.
3. Bronstein D.M., Przewlocki R., Akil H. Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res 1990, 519:102-111.
4. Canteras N.S., Simerly R.B., Swanson L.W. Connections of the posterior nucleus of the amygdala. J Comp Neurol 1992, 324:143-179.
5. Canteras N.S., Simerly R.B., Swanson L.W. Organization of projections from the medial nucleus of the amygdala: a PHAL study in the rat. J Comp Neurol 1995, 360:213-245.
6. Chen S.A., O'Dell L.E., Hoefer M.E., Greenwell T.N., Zorrilla E.P., Koob G.F. Unlimited access to heroin self-administration: independent motivational markers of opiate dependence. Neuropsychopharmacology 2006, 31:2692-2707.
7. Chen X., Herbert J. Regional changes in c-fos expression in the basal forebrain and brainstem during adaptation to repeated stress: correlations with cardiovascular, hypothermic and endocrine responses. Neuroscience 1995, 64:675-685.
8. Choleris E., Little S.R., Mong J.A., Puram S.V., Langer R., Pfaff D.W. Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice. Proc Natl Acad Sci U S A 2007, 104:4670-4675.
9. Civelli O., Birnberg N., Herbert E. Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissues from different species. J Biol Chem 1982, 257:6783-6787.
10. Contarino A., Papaleo F. The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. Proc Natl Acad Sci U S A 2005, 102:18649-18654.
11. Dai S., Corrigall W.A., Coen K.M., Kalant H. Heroin self-administration by rats: influence of dose and physical dependence. Pharmacol Biochem Behav 1989, 32:1009-1015.
12. Davis M., Shi C. The amygdala. Curr Biol 2000, 10:R131.
13. Dayas C.V., Buller K.M., Day T.A. Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala. Eur J Neurosci 1999, 11:2312-2322.
14. Dole V.P., Nyswander M.E., Kreek M.J. Narcotic blockade-a medical technique for stopping heroin use by addicts. Trans Assoc Am Phys 1966, 79:122-136.
15. Dulac C., Torello A.T. Molecular detection of pheromone signals in mammals: from genes to behaviour. Nat Rev Neurosci 2003, 4:551-562.
16. Eisch A.J., Barrot M., Schad C.A., Self D.W., Nestler E.J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A 2000, 97:7579-7584.
17. Ferguson J.N., Aldag J.M., Insel T.R., Young L.J. Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 2001, 21:8278-8285.
18. Franklin K.B.J., Paxinos G. The mouse brain in stereotaxic coordinates 1997, Academic Press, California.
19. Gellert V.F., Holtzman S.G. Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 1978, 205:536-546.
20. Georges F., Stinus L., Le Moine C. Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur J Neurosci 2000, 12:4475-4486.
21. Glass M.J., Hegarty D.M., Oselkin M., Quimson L., South S.M., Xu Q., Pickel V.M., Inturrisi C.E. Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice. Exp Neurol 2008, 213:57-70.
22. Gong S., Zheng C., Doughty M.L., Losos K., Didkovsky N., Schambra U.B., Nowak N.J., Joyner A., Leblanc G., Hatten M.E., Heintz N. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 2003, 425:917-925.
23. Goosens K.A., Maren S. Contextual and auditory fear conditioning are mediated by the lateral, basal, and central amygdaloid nuclei in rats. Learn Mem 2001, 8:148-155.
24. Grauerholz B.L., Jacobson J.D., Handler M.S., Millington W.R. Detection of pro-opiomelanocortin mRNA in human and rat caudal medulla by RT-PCR. Peptides 1998, 19:939-948.
25. Gudehithlu K.P., Tejwani G.A., Bhargava H.N. Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats. Brain Res 1991, 553:284-290.
26. Hale M.W., Bouwknecht J.A., Spiga F., Shekhar A., Lowry C.A. Exposure to high- and low-light conditions in an open-field test of anxiety increases c-Fos expression in specific subdivisions of the rat basolateral amygdaloid complex. Brain Res Bull 2006, 71:174-182.
27. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., Cullinan W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003, 24:151-180.
28. Jin C., Araki H., Nagata M., Suemaru K., Shibata K., Kawasaki H., Hamamura T., Gomita Y. Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure. Psychopharmacology (Berl) 2004, 175:428-435.
29. Johnston R.E., Peng A. Memory for individuals: hamsters (Mesocricetus auratus) require contact to develop multicomponent representations (concepts) of others. J Comp Psychol 2008, 122:121-131.
30. Kang N., Baum M.J., Cherry J.A. A direct main olfactory bulb projection to the 'vomeronasal' amygdala in female mice selectively responds to volatile pheromones from males. Eur J Neurosci 2009, 29:624-634.
31. Kempermann G., Gage F.H. Experience-dependent regulation of adult hippocampal neurogenesis: effects of long-term stimulation and stimulus withdrawal. Hippocampus 1999, 9:321-332.
32. Kiefer F., Wiedemann K. Neuroendocrine pathways of addictive behaviour. Addict Biol 2004, 9:205-212.
33. Kreek M.J. Opiates, opioids and addiction. Mol Psychiatry 1996, 1:232-254.
34. Kreek M.J., Schlussman S.D., Reed B., Zhang Y., Nielsen D.A., Levran O., Zhou Y., Butelman E.R. Bidirectional translational research: progress in understanding addictive diseases. Neuropharmacology 2009, 56(Suppl 1):32-43.
35. Kruzich P.J., Chen A.C., Unterwald E.M., Kreek M.J. Subject-regulated dosing alters morphine self-administration behavior and morphine-stimulated [35S]GTPgammaS binding. Synapse 2003, 47:243-249.
36. Kuhn H.G., Dickinson-Anson H., Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 1996, 16:2027-2033.
37. Langerman L., Piscoun B., Bansinath M., Shemesh Y., Turndorf H., Grant G.J. Quantifiable dose-dependent withdrawal after morphine discontinuation in a rat model. Pharmacol Biochem Behav 2001, 68:1-6.
38. Li H.Y., Sawchenko P.E. Hypothalamic effector neurons and extended circuitries activated in " neurogenic" stress: a comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoid levels. J Comp Neurol 1998, 393:244-266.
39. Lu L., Hope B.T., Dempsey J., Liu S.Y., Bossert J.M., Shaham Y. Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci 2005, 8:212-219.
40. Martinez R.C., Carvalho-Netto E.F., Ribeiro-Barbosa E.R., Baldo M.V., Canteras N.S. Amygdalar roles during exposure to a live predator and to a predator-associated context. Neuroscience 2011, 172:314-328.
41. Miyata T., Maeda T., Lee J.E. NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev 1999, 13:1647-1652.
42. Mocchetti I., Ritter A., Costa E. Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats. J Mol Neurosci 1989, 1:33-38.
43. Newman S.W. The medial extended amygdala in male reproductive behavior. A node in the mammalian social behavior network. Ann N Y Acad Sci 1999, 877:242-257.
44. Niikura K., Narita M., Nakamura A., Okutsu D., Ozeki A., Kurahashi K., Kobayashi Y., Suzuki M., Suzuki T. Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state. Neurosci Lett 2008, 435:257-262.
45. Overstreet L.S., Hentges S.T., Bumaschny V.F., de Souza F.S., Smart J.L., Santangelo A.M., Low M.J., Westbrook G.L., Rubinstein M. A transgenic marker for newly born granule cells in dentate gyrus. J Neurosci 2004, 24:3251-3259.
46. Petrovich G.D., Risold P.Y., Swanson L.W. Organization of projections from the basomedial nucleus of the amygdala: a PHAL study in the rat. J Comp Neurol 1996, 374:387-420.
47. Picetti R., Caccavo J.A., Ho A., Kreek M.J. Dose escalation and dose preference in extended-access heroin self-administration in Lewis and Fischer rats. Psychopharmacology (Berl) 2012, 220:163-172.
48. Pinto S., Roseberry A.G., Liu H., Diano S., Shanabrough M., Cai X., Friedman J.M., Horvath T.L. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004, 304:110-115.
49. Poulin G., Lebel M., Chamberland M., Paradis F.W., Drouin J. Specific protein-protein interaction between basic helix-loop-helix transcription factors and homeoproteins of the Pitx family. Mol Cell Biol 2000, 20:4826-4837.
50. Rizos Z., Ovari J., Leri F. Reconditioning of heroin place preference requires the basolateral amygdala. Pharmacol Biochem Behav 2005, 82:300-305.
51. Rogan M.T., LeDoux J.E. Emotion: systems, cells, synaptic plasticity. Cell 1996, 85:469-475.
52. Rothwell P.E., Thomas M.J., Gewirtz J.C. Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure. Neuropsychopharmacology 2009, 34:2285-2295.
53. Schlussman S.D., Cassin J., Zhang Y., Levran O., Ho A., Kreek M.J. Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice. strain and heroin effects. Pharmacol Biochem Behav 2011, 100:8-16.
54. Schwab M.H., Bartholomae A., Heimrich B., Feldmeyer D., Druffel-Augustin S., Goebbels S., Naya F.J., Zhao S., Frotscher M., Tsai M.J., Nave K.A. Neuronal basic helix-loop-helix proteins (NEX and BETA2/Neuro D) regulate terminal granule cell differentiation in the hippocampus. J Neurosci 2000, 20:3714-3724.
55. Segovia S., Guillamon A. Sexual dimorphism in the vomeronasal pathway and sex differences in reproductive behaviors. Brain Res Rev 1993, 18:51-74.
56. Seip K.M., Reed B., Ho A., Kreek M.J. Measuring the incentive value of escalating doses of heroin in heroin-dependent Fischer rats during acute spontaneous withdrawal. Psychopharmacology (Berl) 2012, 219:59-72.
57. Shalev U., Morales M., Hope B., Yap J., Shaham Y. Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology (Berl) 2001, 156:98-107.
58. Spanagel R., Almeida O.F., Bartl C., Shippenberg T.S. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology (Berl) 1994, 115:121-127.
59. van Praag H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci 1999, 2:266-270.
60. Will M.J., Franzblau E.B., Kelley A.E. The amygdala is critical for opioid-mediated binge eating of fat. Neuroreport 2004, 15:1857-1860.
61. Wood R.I. Integration of chemosensory and hormonal input in the male Syrian hamster brain. Ann N Y Acad Sci 1998, 855:362-372.
62. Zhou Y., Leri F., Cummins E., Hoeschele M., Kreek M.J. Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin. Neuropsychopharmacology 2008, 33:226-236.
63. Zhou Y., Spangler R., LaForge K.S., Maggos C.E., Ho A., Kreek M.J. Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: correlation with POMC mRNA. Peptides 1996, 17:435-441.